Evidence map›Paper›PMID 33649498›Full record

ReviewExperimental & molecular medicine2021

Zebrafish as an animal model for biomedical research.

Tae-Young Choi, Tae-Ik Choi, Yu-Ri Lee, Seong-Kyu Choe, Cheol-Hee Kim

Abstract readReview
In one paragraph

Review in Experimental & molecular medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 245 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
245citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

245 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Biochemistry and biophysics reports · 2026
    Review
  5. Article
  6. Chemical science · 2026
    Article
  7. Article
  8. Article
  9. A zebrafish module for genetic problem-solving.Journal of microbiology & biology education · 2026
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

185 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tae-Young ChoiDepartment of Pathology, Digestive Disease Research Institute, Wonkwang University, Iksan, Jeonbuk, 54538, Republic of Korea. choity76@wku.ac.kr.
Tae-Ik ChoiDepartment of Biology, Chungnam National University, Daejeon, 34134, Republic of Korea.
Yu-Ri LeeDepartment of Biology, Chungnam National University, Daejeon, 34134, Republic of Korea.
Seong-Kyu ChoeDepartment of Biomedical Science, Graduate School, Wonkwang University, Iksan, Jeonbuk, 54538, Republic of Korea. seongkyu642@wku.ac.kr.ORCID http://orcid.org/0000-0002-2102-973X
Cheol-Hee KimDepartment of Biology, Chungnam National University, Daejeon, 34134, Republic of Korea. zebrakim@cnu.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Zebrafish have several advantages compared to other vertebrate models used in modeling human diseases, particularly for large-scale genetic mutant and therapeutic compound screenings, and other biomedical research applications. With the impactful developments of CRISPR and next-generation sequencing technology, disease modeling in zebrafish is accelerating the understanding of the molecular mechanisms of human genetic diseases. These efforts are fundamental for the future of precision medicine because they provide new diagnostic and therapeutic solutions. This review focuses on zebrafish disease models for biomedical research, mainly in developmental disorders, mental disorders, and metabolic diseases.

Indexed as

Biomedical ResearchDisease Models, AnimalAnimalsDevelopmental DisabilitiesHumansMental DisordersMetabolic DiseasesZebrafish

Identifiers

PMID33649498
PMCPMC8080808

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.